Potential role and therapeutic interests of myo-inositol in metabolic diseases

ML Croze, CO Soulage - Biochimie, 2013 - Elsevier
Several inositol isomers and in particular myo-inositol (MI) and D-chiro-inositol (DCI), were
shown to possess insulin-mimetic properties and to be efficient in lowering post-prandial …

Results from the International Consensus Conference on Myo-inositol and d-chiro-inositol in Obstetrics and Gynecology: the link between metabolic syndrome and …

F Facchinetti, M Bizzarri, S Benvenga, R D'Anna… - European Journal of …, 2015 - Elsevier
In recent years, interest has been focused to the study of the two major inositol
stereoisomers: myo-inositol (MI) and d-chiro-inositol (DCI), because of their involvement, as …

Myo-inositol effects in women with PCOS: a meta-analysis of randomized controlled trials

V Unfer, F Facchinetti, B Orrù, B Giordani… - Endocrine …, 2017 - ec.bioscientifica.com
Myo-inositol (MI) supplementation in women with polycystic ovary syndrome (PCOS) has
been evaluated over the last years. Many hormonal and reproductive impairments …

myo-Inositol Supplementation and Onset of Gestational Diabetes Mellitus in Pregnant Women With a Family History of Type 2 Diabetes: A prospective, randomized …

R D'Anna, A Scilipoti, D Giordano, C Caruso… - Diabetes …, 2013 - Am Diabetes Assoc
OBJECTIVE To check the hypothesis that myo-inositol supplementation may reduce
gestational diabetes mellitus (GDM) onset in pregnant women with a family history of type 2 …

The effectiveness of Myo‐inositol and D‐chiro inositol treatment in type 2 diabetes

B Pintaudi, G Di Vieste… - International journal of …, 2016 - Wiley Online Library
Inositol has been used as a supplement in treating several pathologies such as PCOS,
metabolic syndrome, and gestational diabetes. Both myo‐inositol and its isomer d‐chiro …

Myo-inositol supplementation for prevention of gestational diabetes in obese pregnant women: a randomized controlled trial

R D'Anna, A Di Benedetto, A Scilipoti… - Obstetrics & …, 2015 - journals.lww.com
OBJECTIVE: To evaluate whether myo-inositol supplementation, an insulin sensitizer,
reduces the rate of gestational diabetes mellitus (GDM) and lowers insulin resistance in …

Metabolic syndrome, autoimmunity and rheumatic diseases

G Medina, O Vera-Lastra, AL Peralta-Amaro… - Pharmacological …, 2018 - Elsevier
Metabolic syndrome (MetS) is a cluster of metabolic and cardiovascular (CV) risk factors
including obesity and visceral adiposity, insulin resistance, dyslipidemia and hypertension …

Myoinositol supplementation on insulin resistance in gestational diabetes

F Corrado, A Santamaria - Glucose Intake and Utilization in Pre-Diabetes …, 2015 - Elsevier
Pregnancy involves a state of physiological insulin resistance that makes it possible for the
fetus to obtain more nutrients from the mother. When the latter is unable to compensate for …

Inositol's and other nutraceuticals' synergistic actions counteract insulin resistance in polycystic ovarian syndrome and metabolic syndrome: state-of-the-art and future …

C Paul, AS Laganà, P Maniglio, O Triolo… - Gynecological …, 2016 - Taylor & Francis
The incidence of metabolic syndrome (MetS), type II diabetes (T2D) and polycystic ovarian
syndrome (PCOS) has been progressively increasing. Insulin resistance (InsR) seems to …

Myo-inositol for insulin resistance, metabolic syndrome, polycystic ovary syndrome and gestational diabetes

JJ DiNicolantonio, JH O'Keefe - Open Heart, 2022 - openheart.bmj.com
Myo-inositol, also known as inositol (cyclohexanehexol), is a cyclic carbohydrate with six
hydroxyl groups. 1 For a long time, it was considered a B vitamin (vitamin B8). However, it is …